Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study.

The CHARM study aimed to improve access to genomic health care for marginalized populations at risk for hereditary cancer syndromes. The study utilized communication strategies and digital materials to engage patients and streamline the genomics care process. The results showed that the approach successfully reached patients who may be missed by traditional care pathways and highlighted the importance of relationship-oriented communication strategies and remote technologies in making genetic counseling more inclusive and accessible. The study also emphasized the importance of a diverse research workforce and ongoing relationships with patient advisors to improve community engagement. Overall, the CHARM study demonstrated the value of multilevel, health system-embedded interventions in genomic medicine and highlighted the need for further research to expand the reach of genomic care. [Extracted from the article]